rs13334376

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001352019.2(LMF1):​c.-135+10144G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00075 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0075 ( 164 hom. )

Consequence

LMF1
NM_001352019.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.00

Publications

7 publications found
Variant links:
Genes affected
LMF1 (HGNC:14154): (lipase maturation factor 1) Involved in triglyceride metabolic process. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum membrane. Implicated in familial lipase maturation factor 1 deficiency. [provided by Alliance of Genome Resources, Apr 2022]
LMF1 Gene-Disease associations (from GenCC):
  • lipase deficiency, combined
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 16-971001-C-A is Benign according to our data. Variant chr16-971001-C-A is described in ClinVar as Benign. ClinVar VariationId is 1242679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000749 (40/53398) while in subpopulation AFR AF = 0.00223 (17/7620). AF 95% confidence interval is 0.00142. There are 0 homozygotes in GnomAd4. There are 18 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 164 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LMF1NM_022773.4 linkc.-21G>T upstream_gene_variant ENST00000262301.16 NP_073610.2 Q96S06-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LMF1ENST00000262301.16 linkc.-21G>T upstream_gene_variant 5 NM_022773.4 ENSP00000262301.12 Q96S06-1

Frequencies

GnomAD3 genomes
AF:
0.000749
AC:
40
AN:
53384
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00223
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000742
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000744
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000619
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0761
AC:
5608
AN:
73662
AF XY:
0.0733
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.0599
Gnomad ASJ exome
AF:
0.0417
Gnomad EAS exome
AF:
0.0281
Gnomad FIN exome
AF:
0.0791
Gnomad NFE exome
AF:
0.0874
Gnomad OTH exome
AF:
0.0715
GnomAD4 exome
AF:
0.00750
AC:
4387
AN:
585148
Hom.:
164
Cov.:
0
AF XY:
0.00838
AC XY:
2392
AN XY:
285380
show subpopulations
African (AFR)
AF:
0.0325
AC:
180
AN:
5532
American (AMR)
AF:
0.0459
AC:
505
AN:
10994
Ashkenazi Jewish (ASJ)
AF:
0.00477
AC:
53
AN:
11100
East Asian (EAS)
AF:
0.00624
AC:
86
AN:
13786
South Asian (SAS)
AF:
0.0136
AC:
292
AN:
21410
European-Finnish (FIN)
AF:
0.0215
AC:
395
AN:
18350
Middle Eastern (MID)
AF:
0.00428
AC:
8
AN:
1870
European-Non Finnish (NFE)
AF:
0.00559
AC:
2676
AN:
478582
Other (OTH)
AF:
0.00816
AC:
192
AN:
23524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
160
320
480
640
800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000749
AC:
40
AN:
53398
Hom.:
0
Cov.:
0
AF XY:
0.000680
AC XY:
18
AN XY:
26458
show subpopulations
African (AFR)
AF:
0.00223
AC:
17
AN:
7620
American (AMR)
AF:
0.000742
AC:
4
AN:
5388
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1864
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1954
South Asian (SAS)
AF:
0.000742
AC:
1
AN:
1348
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4888
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
154
European-Non Finnish (NFE)
AF:
0.000619
AC:
18
AN:
29088
Other (OTH)
AF:
0.00
AC:
0
AN:
870
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
3.5
DANN
Benign
0.32
PhyloP100
0.0
PromoterAI
-0.10
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13334376; hg19: chr16-1021001; API